Literature DB >> 9555773

Coronary angioplasty outcomes in the Healthcare Cost and Utilization Project, 1993-1994.

C Maynard1, M K Chapko, N R Every, D C Martin, J L Ritchie.   

Abstract

It is estimated that >400,000 percutaneous transluminal coronary angioplasty (PTCA) procedures are performed in the Unites States annually. This study reports patient characteristics and outcomes for 163,527 PTCAs performed in 214 hospitals in 17 states from 1993 to 1994. These hospitals were a 20% random sample of hospitals in the Healthcare Cost and Utilization Project, which was designed to reflect hospitalization in the United States, generally. Cases with International Classification of Diseases, 9th Revision, Clinical Modification procedure codes 36.01, 36.02, and 36.05 were defined as PTCA and were categorized as to whether acute myocardial infarction (AMI) was the principal discharge diagnosis. The average age of 44,270 AMI discharges (27%) was 62 +/- 12 years and that of 119,257 no-AMI cases (73%) was 64 +/- 11 years; 1/3 of both groups were women, 88% were white, and almost 90% had Medicare or private insurance as the primary payer. The states contributing the most cases were Florida (26%), California (12%), and Wisconsin (10%). Hospital mortality was 1.7% overall and was 3.8% for AMI and 0.8% for no-AMI cases. Bypass surgery performed during the same admission was 3.4% overall and was 4.5% and 3.0% for AMI and no-AMI cases, respectively. Multivariate analysis showed that advanced age, diabetes, female gender, and Medicaid payer status were associated with increased risk of mortality. National estimates from this 20% sample indicate that >850,000 PTCAs were performed in the 2 years, with 452,319 cases estimated for 1994. In 1994 there were an estimated 2,789 deaths and 9,903 bypass surgeries in the no-AMI subset of 327,856 procedures. For the AMI group of 124,463 procedures, there were 4,486 deaths and 5,799 bypass surgeries in 1994. This study of PTCA outcomes contains the largest number of cases as well as the most representative sample reported to date.

Entities:  

Mesh:

Year:  1998        PMID: 9555773     DOI: 10.1016/s0002-9149(98)00017-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Secondary data bases and their use in outcomes research: a review of the area resource file and the Healthcare Cost and Utilization Project.

Authors:  A E Best
Journal:  J Med Syst       Date:  1999-06       Impact factor: 4.460

Review 2.  Abciximab. A pharmacoeconomic review of its use in percutaneous coronary revascularisation.

Authors:  C J Dunn; R H Foster
Journal:  Pharmacoeconomics       Date:  1999-12       Impact factor: 4.981

3.  Hospital percutaneous coronary intervention volume and patient mortality, 1998 to 2000: does the evidence support current procedure volume minimums?

Authors:  Andrew J Epstein; Saif S Rathore; Kevin G M Volpp; Harlan M Krumholz
Journal:  J Am Coll Cardiol       Date:  2004-05-19       Impact factor: 24.094

4.  Recent US Patterns and Predictors of Prevalent Diabetes among Acute Myocardial Infarction Patients.

Authors:  Bruce Ovbiagele; Daniela Markovic; Gregg C Fonarow
Journal:  Cardiol Res Pract       Date:  2011-04-07       Impact factor: 1.866

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.